GB201203681D0 - Androgen receptor antagonists for treatment of prostate cancer - Google Patents

Androgen receptor antagonists for treatment of prostate cancer

Info

Publication number
GB201203681D0
GB201203681D0 GBGB1203681.0A GB201203681A GB201203681D0 GB 201203681 D0 GB201203681 D0 GB 201203681D0 GB 201203681 A GB201203681 A GB 201203681A GB 201203681 D0 GB201203681 D0 GB 201203681D0
Authority
GB
United Kingdom
Prior art keywords
treatment
prostate cancer
receptor antagonists
androgen receptor
androgen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1203681.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB1203681.0A priority Critical patent/GB201203681D0/en
Publication of GB201203681D0 publication Critical patent/GB201203681D0/en
Ceased legal-status Critical Current

Links

GBGB1203681.0A 2012-03-02 2012-03-02 Androgen receptor antagonists for treatment of prostate cancer Ceased GB201203681D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1203681.0A GB201203681D0 (en) 2012-03-02 2012-03-02 Androgen receptor antagonists for treatment of prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1203681.0A GB201203681D0 (en) 2012-03-02 2012-03-02 Androgen receptor antagonists for treatment of prostate cancer

Publications (1)

Publication Number Publication Date
GB201203681D0 true GB201203681D0 (en) 2012-04-18

Family

ID=46002999

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1203681.0A Ceased GB201203681D0 (en) 2012-03-02 2012-03-02 Androgen receptor antagonists for treatment of prostate cancer

Country Status (1)

Country Link
GB (1) GB201203681D0 (en)

Similar Documents

Publication Publication Date Title
IL288181A (en) Methods of treating cancer
IL258612B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
IL304337A (en) Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP2680853A4 (en) Treatment of cancer with dopamine receptor antagonists
IL227718A0 (en) Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer
HK1214128A1 (en) Treatment of cancer
ZA201507734B (en) Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer
HK1204956A1 (en) Treatment of cancer
GB201217892D0 (en) Treatment of cancer
SI2892925T1 (en) Combination treatment of cancer
GB201203681D0 (en) Androgen receptor antagonists for treatment of prostate cancer
IL237229A0 (en) Methods for treatment of cancer using lipoplatin
GB201217890D0 (en) Treatment of cancer
ZA201307677B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
GB201222950D0 (en) Combination treatment of cancer
GB201222949D0 (en) Combination Treatment of Cancer
GB201222952D0 (en) Treatent of cancer
GB201208296D0 (en) Treatment of cancer
BR112013023449A2 (en) combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)